Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABAB receptor system

1 Monoarthritis was induced in Lewis rats by interdermal injection in the left hind paw of a suspension of Mycobacterium tubercolusis in mineral oil (500 μg 100 μ1−1). Controls were injected with 100 μ1 mineral oil. 2 Withdrawal latencies to thermal stimuli of the inflamed paw, the contralateral and both paws of control rats were measured at daily intervals after injection by the plantar test. 3 After detection of the pain threshold, rat spinal cords were removed and horizontal dorsal slices were mounted in a 3‐compartment bath to measure electrically‐evoked release of substance P‐like immunoreactivity (SP‐LI). 4 The inflamed paw of monoarthritic rats exhibited a lower pain threshold to thermal stimuli than the contralateral paw of the same animals and both paws of control rats. Inflamed paw hyperalgesia was maximal two days after injection, and declined gradually between 7 to 21 days with no evidence of excitability of withdrawal reflexes after 28 days. 5 During the 28 days study, monoarthritic rats gained less weight than control rats. 6 Electrical stimulation of the dorsal roots attached to rat isolated spinal cord slices induced a significant increase (174 ± 18% of basal outflow which was 30.3 fmol 8 ml−1 n = 5) in SP‐LI release. 7 One‐week after induction of inflammation no differences in the amount of SP‐LI released from the spinal cord of incomplete Freund's adjuvant‐treated rats (IFA) and Freund's adjuvant‐treated rats (CFA) were detected. Two weeks after, CFA spinal cord tended to release more SP‐LI than IFA cords and, 21 days after injection, the spinal cord of CFA rats released significantly more peptide than IFA rats (17.8 ± 2.8 fmol ml−1, n = 12 and 6.9 ± 3.2 fmol ml−1, n = 9, respectively). 8 Twenty‐one days after treatment, the evoked release from monoarthritic rat spinal cords was increased by 263 ± 42% (n = 3) in the presence of the GABAB receptor antagonist, CGP 36742 (100 μm) which also significantly potentiated monoarthritis‐induced hyperalgesia up to 45min after injection (100mg kg−1, i.p.). 9 These findings may provide a basis for a novel approach to chronic pain therapy but also an explanation for the lack of analgesia produced by the GABAB agonist, baclofen, in chronic as compared to acute pain.

[1]  N. Bowery,et al.  Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically‐evoked substance P release from rat spinal cord , 1994, British journal of pharmacology.

[2]  W. Ferrell,et al.  Alteration of substance P-mediated vasodilatation and sympathetic vasoconstriction in the rat knee joint by adjuvant-induced inflammation , 1994, Neuroscience Letters.

[3]  D. A. Walsh,et al.  Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord , 1993, Neuroscience.

[4]  H. Schaible,et al.  Afferent and spinal mechanisms of joint pain , 1993, Pain.

[5]  N. Bowery,et al.  Gamma-aminobutyric acidB, but not gamma-aminobutyric acidA receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro. , 1993, The Journal of pharmacology and experimental therapeutics.

[6]  J. Seckl,et al.  A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose , 1993, Journal of Neuroscience Methods.

[7]  W. Froestl,et al.  The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. , 1993, European journal of pharmacology.

[8]  W. Ferrell,et al.  Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging , 1993, Neuroscience.

[9]  W. Willis,et al.  Neural changes in acute arthritis in monkeys. III. Changes in substance P, calcitonin gene-related peptide and glutamate in the dorsal horn of the spinal cord , 1992, Brain Research Reviews.

[10]  T. Tölle,et al.  Increase in GABAergic Cells and GABA Levels in the Spinal Cord in Unilateral Inflammation of the Hindlimb in the Rat , 1992, The European journal of neuroscience.

[11]  J. Seckl,et al.  Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant monoarthritis in the rat , 1992, Neuroscience Letters.

[12]  R. Przewłocki,et al.  Time-dependent changes in the activity of opioid systems in the spinal cord of monoarthritic rats—A release and in situ hybridization study , 1992, Neuroscience.

[13]  C. Ghelardini,et al.  CGP 35348, a new GABAB antagonist, prevents antinociception and muscle‐relaxant effect induced by baclofen , 1991, British journal of pharmacology.

[14]  H. Schaible,et al.  Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes , 1990, Brain Research.

[15]  J. McKenzie,et al.  GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord , 1989, Neuroscience.

[16]  S. Nakanishi,et al.  Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible involvement of substance P-containing spinal neurons in nociception , 1989, Neuroscience Letters.

[17]  B. Morris,et al.  Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat , 1988, Pain.

[18]  H. Schaible,et al.  Time course of mechanosensitivity changes in articular afferents during a developing experimental arthritis. , 1988, Journal of neurophysiology.

[19]  A. Herz,et al.  Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds , 1988, Pharmacology Biochemistry and Behavior.

[20]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[21]  G. Fromm,et al.  Comparison of L‐baclofen and racernic baclofen in trigeminal neuralgia , 1987, Neurology.

[22]  V. Go,et al.  Release of substance P from the cat spinal cord. , 1987, The Journal of physiology.

[23]  H. Takagi,et al.  Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats , 1987, Neuroscience Letters.

[24]  M. Geffard,et al.  Anatomical distribution and ultrastructural organization of the gabaergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies , 1987, Neuroscience.

[25]  F. Colpaert,et al.  Evidence that adjuvant arthritis in the rat is associated with chronic pain , 1987, Pain.

[26]  J. Sawynok.  GABAergic mechanisms of analgesia: An update , 1987, Pharmacology Biochemistry and Behavior.

[27]  A. Herz,et al.  A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  M. Moskowitz,et al.  Intraneuronal substance P contributes to the severity of experimental arthritis. , 1984, Science.

[29]  F. Artaud,et al.  Basic and Regulatory Mechanisms of In Vitro Release of Met‐Enkephalin from the Dorsal Zone of the Rat Spinal Cord , 1984, Journal of neurochemistry.

[30]  G. Guilbaud,et al.  The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats , 1983, Brain Research.

[31]  T. Yaksh,et al.  Baclofen is antinociceptive in the spinal intrathecal space of animals. , 1978, European journal of pharmacology.

[32]  G. Nilsson,et al.  Substance p: localization in the central nervous system and in some primary sensory neurons , 1975, Science.

[33]  F. Perlík,et al.  Breeding experiments on the frequency of adjuvant arthritis in the rat. , 1973, Annals of the rheumatic diseases.

[34]  N. Bowery.  GABAB receptor pharmacology. , 1993, Annual review of pharmacology and toxicology.

[35]  J. Morley,et al.  Peptidergic regulation of feeding. , 1985, International review of neurobiology.

[36]  A. G. Brown,et al.  The dorsal horn of the spinal cord. , 1982, Quarterly journal of experimental physiology.

[37]  G. Fischbach,et al.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. , 1979, Proceedings of the National Academy of Sciences of the United States of America.